Latest | Instant Finance & Market News_第286页

09:58

[ Global X China Semiconductor ETF (03191.HK) Falls 5.42% in Morning Trade, Latest NAV at HKD 109.526 ] NewTimeSpace News: As of 09:56 on July 16, Global X China Semiconductor ETF (03191.HK) was down 5.42%, with the latest price at HKD 103.000.

Tag： Global X China Semiconductor ETF 03191.HK ETF

09:54

[ Hang Seng TECH Index ETF (03032.HK) Rises 2.57% in Morning Trade, AUM at HKD 6.680 Billion ] NewTimeSpace News: As of 09:51 on July 16, Hang Seng TECH Index ETF (03032.HK) was up 2.57%, with the latest price at HKD 4.860.

Tag： Hang Seng TECH Index ETF ETF 03032.HK

09:47

[ Big Catering HKEX IPO Application Lapsed, Leading Domestic Pizza Operator in China ] NewTimeSpace News: The Hong Kong listing application of Big Catering International Holding Co., Ltd. submitted on 16 January 2026 has lapsed upon expiry of the six-month validity period. BOC International acted as the original sole sponsor. According to CIC data, measured by GMV for the nine months ended 30 September 2025, the Company ranked first among domestic pizza restaurants, buffet restaurants and western casual dining operators in China. As of the latest practicable date, the Group operated 387 restaurants covering 127 cities across Chinese mainland.

Tag： Big Catering IPO IPO application lapsed

09:40

[ DREAM GARDEN HKEX IPO Application Lapsed, Leading Domestic Brand Across Multiple Categories ] NewTimeSpace News: The Hong Kong listing application of Shandong Huawutang Cosmetics Co., Ltd. (Dream Garden) submitted on 16 January 2026 has lapsed upon the expiry of the six-month validity period. CITIC Securities served as the original sole sponsor. According to Frost & Sullivan, measured by retail sales in 2024, the Company ranks first among domestic brands for body lotion, body scrub and cleansing mousse.

Tag： Dream Garden IPO IPO application lapsed

09:32

[ MEDITRUST HEALTH HKEX IPO Application Lapsed, China’s Largest Diversified Pharmaceutical Payment Platform ] NewTimeSpace News: The Hong Kong listing application of Shanghai MediTrust Health Technology Group Co., Ltd., initially filed on 16 January 2026, has lapsed upon the expiry of the six-month validity period. Goldman Sachs, CICC and HSBC acted as the original joint sponsors. According to Frost & Sullivan, the Company is China’s largest diversified pharmaceutical payment platform, ranking first by number of partnered pharmaceutical enterprises in the innovative smart medicine solution market and by volume of processed commercial health insurance policies in the innovative smart health insurance solution market.

Tag： MediTrust Health IPO IPO application lapsed

09:19

[ GEEKPLUS-W(02590.HK) will spend HKD 12.11 million to repurchase 1.2 million shares on Jul 15, 2026 ] NewTimeSpace (newtimespace.com) News, GEEKPLUS-W(02590.HK) will spend HKD 12.11 million to repurchase 1.2 million shares on Jul 15, 2026.

Tag： GEEKPLUS-W 02590.HK NewTimeSpace

09:18

[ YONGDA AUTO (03669.HK) plans to issue in total 73.16 million shares ] NewTimeSpace News: YONGDA AUTO (03669.HK) plans to issue in total 73.16 million shares.

Tag： YONGDA AUTO 03669.HK Share Issue

09:14

[ YONYOU NETWORK TECHNOLOGY CO., LTD.: Submits Third HKEX Listing Application, Ranked No.1 in China’s Enterprise Software & Service Market ] NewTimeSpace News: Yonyou Network Technology Co., Ltd. filed its third listing application with HKEX on 15 July, with CMB International and CITIC Securities International acting as joint sponsors. According to Frost & Sullivan, measured by 2025 revenue, the Company is the largest participant in China’s enterprise software and service market with a market share of 3.8%, and also ranks first among domestic Chinese enterprise software companies based on overseas revenue in 2025.

Tag： Yonyou Network IPO file a listing application

09:12

[ Dobot (02432.HK) ChiNext IPO to Be Reviewed by Listing Committee on July 22, Only 86 Days from Acceptance to Hearing ] Dobot announced on July 15 that its ChiNext IPO will be reviewed by the listing committee on July 22, taking only 86 days from acceptance to hearing, sponsored by Guotai Haitong Securities with planned proceeds of approximately RMB1.2 billion. The Company ranked first globally in collaborative robot shipments in 2025 with cumulative installations exceeding 100,000 units, and H1 2026 embodied intelligence shipment value exceeded RMB40 million with 231 accumulated customers. Revenue grew from RMB287 million in 2023 to RMB493 million in 2025, with net losses narrowing year by year. Proceeds allocation: RMB550 million for multi-legged robots and RMB250 million for humanoid robots. Listed on the Hong Kong Stock Exchange in December 2024, this A-share listing if successful would become the first "H-to-A" case in the Greater Bay Area following the Shenzhen comprehensive reform pilot program.

Tag： DOBOT 02432.HK H+A

08:16

[ Lvji Technology (01745.HK) Enters Loan Agreement at Fixed Annual Interest Rate of 3.2% for Working Capital ] Lvji Technology announced on July 15 that its wholly-owned subsidiary Lvji International Travel entered into a corporate loan contract with Guangzhou Rural Commercial Bank Huangpu Branch for RMB10 million, with a term of 12 months (July 10, 2026 to July 10, 2027), a fixed annual interest rate of 3.2% (based on one-year LPR plus 20 basis points), funds for working capital, and guarantee by mortgage and guarantee. The Board considers the loan provides additional funds for daily operations with terms determined through fair negotiation. Rural Commercial Bank is an independent third party, and the loan contract does not constitute a notifiable or connected transaction.

Tag： LVJI TECH 01745.HK loan

08:09

[ Xiamen Jihong (02603.HK) to Place New H-shares Under General Mandate, 80% of Proceeds for Global Business Expansion ] Xiamen Jihong entered into a placing agreement on July 16 with Guotai Junan Securities, China Merchants Securities and Lico Securities to place up to 9.3715 million new H-shares at HK$12.24 per share (approximately 17.02% discount to the last trading day closing price of HK$14.75), with estimated net proceeds of approximately HK$112.8 million. The Placing Shares represent approximately 13.80% of existing H-shares and 2.14% of total issued shares, to be conducted under the general mandate without further shareholders' approval. Proceeds allocation: 80% for global expansion of cross-border social e-commerce (Europe and Middle East overseas expansion HK$45.1 million, self-developed brands HK$33.8 million, Giikin system R&D upgrade HK$11.3 million), 10% for supply chain optimization and paper-based FMCG packaging business expansion, and 10% for working capital. Expected completion date is July 23, 2026, with a 45-day lock-up commitment post-completion.

Tag： JIHONG CO 02603.HK

08:03

[ LongBio Pharma-B (01779.HK) to Introduce Long-term Incentive Mechanism, Plan Cap Not Exceeding 10% of Issued Shares ] LongBio Pharma announced on July 16 that the Board has resolved to propose the adoption of the H-share Share Option Scheme and H-share Share Incentive Scheme, aiming to establish a long-term incentive mechanism, attract and retain core talent, and drive commercial transformation and value enhancement. The plan cap shall not exceed 10% of the total issued shares (excluding treasury shares). The H-share Share Option Scheme will be satisfied through issuing new H-shares or transferring treasury shares, while the H-share Share Incentive Scheme will be satisfied through trustee purchases of new H-shares, secondary market purchases, or treasury shares. Both schemes are subject to approval by special resolution at the EGM and the Stock Exchange listing committee.

Tag： LongBio Pharma 01779.HK

07:53

[ IngDan (00400.HK) Completes Strategic Upgrade to Vertical AI Token Factory Operator, Cumulative Intent Service Orders Exceed US$1 Billion ] IngDan announced on July 16 that the Group has completed its strategic upgrade from an AI hardware distributor to a vertical AI Token factory operator, having cumulatively signed intent service orders exceeding US$1 billion with customers including global tier-one cloud service providers, embodied intelligence companies and AI model companies. The Group has established a vertical industry Token computing power scheduling platform with a revenue sharing model and dual-track infrastructure deployment. The Board believes the Group has established a first-mover advantage in the vertical AI computing power track and will develop Token operation services as its second growth curve. The intent orders are not yet signed contracts, and actual revenue recognition will depend on service agreement execution and business conditions.

Tag： INGDAN 00400.HK AI

07:40

[ XIAOMI-W(01810.HK) will spend HKD 100.69 million to repurchase 3.9 million shares on Jul 15, 2026 ] XIAOMI-W(01810.HK) will spend HKD 100.69 million to repurchase 3.9 million shares on Jul 15, 2026 .

Tag： XIAOMI-W 01810.HK

07:40

[ TCL ELECTRONICS (01070.HK) plans to issue in total 362.86 million shares ] TCL ELECTRONICS (01070.HK) plans to issue in total 362.86 million shares.

Tag： TCL ELECTRONICS 01070.HK

22:22

[ Marketingforce Management(02556.HK): Profit Forecast, Interim Revenue from AI Application Business Expected to Surge 112% to 134% ] NewTimeSpace News: Marketingforce Managementannounced on 15 July that the Group expects its total revenue for the six months ended 30 June 2026 to range from approximately RMB 1.858 billion to RMB 2.054 billion, representing a year-on-year growth of 100% to 121%. Revenue generated from AI application business is projected to hit RMB 1.068 billion to RMB 1.180 billion, up 112% to 134% year on year.

Tag： Marketingforce Management 02556.HK

22:12

[ Hengrui Pharmaceuticals(01276.HK): Concentrated Solution for Injection HRS-8829 Receives Clinical Trial Approval Notice ] NewTimeSpace News: Hengrui Pharmaceuticalsannounced on July 15 that its subsidiary Beijing Shengdi Pharmaceutical Co., Ltd. has obtained the Clinical Trial Approval Notice for Concentrated Solution for Injection HRS-8829 issued and approved by the National Medical Products Administration (NMPA).

Tag： Hengrui Pharmaceuticals 01276.HK

22:06

[ MicroPort Scientific (00853.HK): Proposed Disposal of Controlling Stake in MicroPort Orthopedics (Shanghai) to Tinavi Medical ] NewTimeSpace News: MicroPort Scientific announced on 15 July that its subsidiary Suzhou MicroPort Orthopedics (Group) Co., Limited has entered into a letter of intent with Beijing Tinavi Medical Technology Co., Ltd. Tinavi intends to acquire the controlling equity interest in MicroPort Orthopedics (Shanghai) Co., Ltd. from Suzhou MicroPort and other shareholders of the target company, with the consideration to be settled via the issuance of new shares by Tinavi.

Tag： MicroPort Scientific 00853.HK

22:00

[ Renrui Human Resources(06919.HK): Non-executive Director Wang Xinjie Resigns; Gao Yunjie Appointed ] NewTimeSpace News: Renrui Human Resources announced on 15 July that Ms. Wang Xinjie, Non-executive Director, has resigned with effect from 15 July. On the same day, Ms. Gao Yunjie nominated by Beyondsoft was appointed as a Non-executive Director.

Tag： Renrui Human Resources 06919.HK

19:53

[ Ubox Online (02429.HK): Full Circulation of H Shares Approved by HKEX ] NewTimeSpace News: Ubox Online announced on 15 July that the Hong Kong Stock Exchange (HKEX) has approved the conversion, listing and trading of 40,671,930 domestic shares into H shares on 9 July 2026.

Tag： UBOX ONLINE 02429.HK